130 related articles for article (PubMed ID: 23827786)
1. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes.
Hao J; Zhu L; Li F; Liu Q; Zhao X; Liu S; Xing L; Feng X; Duan H
Exp Cell Res; 2013 Aug; 319(14):2296-306. PubMed ID: 23827786
[TBL] [Abstract][Full Text] [Related]
2. Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice.
Wang H; Zhu L; Hao J; Duan H; Liu S; Zhao S; Liu Q; Liu W
Exp Cell Res; 2015 Aug; 336(1):76-84. PubMed ID: 26112216
[TBL] [Abstract][Full Text] [Related]
3. Phospho-GSK-3β is involved in the high-glucose-mediated lipid deposition in renal tubular cells in diabetes.
Liu W; Hao J; Zhu L; Li F; Liu Q; Liu S; Zhao S; Li H; Duan H
Int J Biochem Cell Biol; 2013 Sep; 45(9):2066-75. PubMed ID: 23880101
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of PRAS40-Thr246 involved in renal lipid accumulation of diabetes.
Hao J; Li F; Liu W; Liu Q; Liu S; Li H; Duan H
J Cell Physiol; 2014 Aug; 229(8):1069-77. PubMed ID: 24347388
[TBL] [Abstract][Full Text] [Related]
5. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells.
Hao J; Zhu L; Zhao S; Liu S; Liu Q; Duan H
Exp Cell Res; 2011 Jul; 317(11):1629-39. PubMed ID: 21320485
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
7. FBXW7 mediates high glucose‑induced SREBP‑1 expression in renal tubular cells of diabetic nephropathy under PI3K/Akt pathway regulation.
Li L; Yang J; Li F; Gao F; Zhu L; Hao J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537812
[TBL] [Abstract][Full Text] [Related]
8. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease.
Yang W; Luo Y; Yang S; Zeng M; Zhang S; Liu J; Han Y; Liu Y; Zhu X; Wu H; Liu F; Sun L; Xiao L
Clin Sci (Lond); 2018 Nov; 132(22):2407-2422. PubMed ID: 30348828
[TBL] [Abstract][Full Text] [Related]
9. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Harima M; Suzuki K; Kawachi H; Watanabe K
J Nutr Biochem; 2013 May; 24(5):796-802. PubMed ID: 22898567
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
[TBL] [Abstract][Full Text] [Related]
11. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.
Uttarwar L; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Feb; 302(3):F329-41. PubMed ID: 22031849
[TBL] [Abstract][Full Text] [Related]
12. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.
Hao J; Liu S; Zhao S; Liu Q; Lv X; Chen H; Niu Y; Duan H
Histochem Cell Biol; 2011 Feb; 135(2):173-81. PubMed ID: 21240525
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of SREBP-1 on diabetic renal tubular lipid accumulation and RNAi-mediated gene silencing study.
Jun H; Song Z; Chen W; Zanhua R; Yonghong S; Shuxia L; Huijun D
Histochem Cell Biol; 2009 Mar; 131(3):327-45. PubMed ID: 19048273
[TBL] [Abstract][Full Text] [Related]
14. High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation.
Hao J; Liu SX; Zhao S; Liu QJ; Liu W; Duan HJ
Br J Nutr; 2012 Jan; 107(1):74-85. PubMed ID: 21733321
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.
Liu YW; Zhang L; Li Y; Cheng YQ; Zhu X; Zhang F; Yin XX
Mol Neurobiol; 2016 Sep; 53(7):4972-80. PubMed ID: 26374551
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men.
Ribback S; Cigliano A; Kroeger N; Pilo MG; Terracciano L; Burchardt M; Bannasch P; Calvisi DF; Dombrowski F
Oncotarget; 2015 May; 6(15):13036-48. PubMed ID: 25948777
[TBL] [Abstract][Full Text] [Related]
17. Prolonged high-glucose exposure decreased SREBP-1/FASN/ACC in Schwann cells of diabetic mice via blocking PI3K/Akt pathway.
Zhu L; Du W; Liu Y; Cheng M; Wang X; Zhang C; Lv X; Li F; Zhao S; Hao J
J Cell Biochem; 2019 Apr; 120(4):5777-5789. PubMed ID: 30362584
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
19. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
20. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
